SKI Market

A+| A| A-|

Indian Indices

Sensex

76,808.48 544.15
( 0.71%)

Global Indices

Nasdaq

51,705.57 482.31
(0.94%)

Dow Jones

7,575.20 122.74
(1.65%)

Hang Seng

69,393.70 76.20
(0.11%)

Nikkei 225

10,435.69 -36.03
(-0.34%)

Forex

USD-INR

94.92 -0.57
(-0.60%)

EUR-INR

109.83 -0.42
(-0.38%)

GBP-INR

127.25 -0.49
(-0.38%)

JPY-INR

0.59 0.00
(-0.48%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Muthoot Finance Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

533398

INE414G01012

940.1098899

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MUTHOOTFIN

12.52

126843.96

EPS(TTM)

Face Value()

Div & Yield %

252.43

0.95

Back

Glaxosmithkline Pharmaceuticals consolidated net profit rises 28.60% in the December 2025 quarter

Feb 09,2026

Net profit of Glaxosmithkline Pharmaceuticals rose 28.60% to Rs 295.62 crore in the quarter ended December 2025 as against Rs 229.88 crore during the previous quarter ended December 2024. Sales rose 9.67% to Rs 1041.26 crore in the quarter ended December 2025 as against Rs 949.42 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1041.26	949.42	10
OPM %	35.66	30.75	-
PBDT	402.27	326.90	23
PBT	381.95	308.10	24
NP	295.62	229.88	29

76,808.48 544.15 ( 0.71%)

51,705.57 482.31 (0.94%)

7,575.20 122.74 (1.65%)

69,393.70 76.20 (0.11%)

10,435.69 -36.03 (-0.34%)

94.92 -0.57 (-0.60%)

109.83 -0.42 (-0.38%)

127.25 -0.49 (-0.38%)

0.59 0.00 (-0.48%)